FI20160181A - Nicotine linseed seed crusade composition of snus - Google Patents
Nicotine linseed seed crusade composition of snusInfo
- Publication number
- FI20160181A FI20160181A FI20160181A FI20160181A FI20160181A FI 20160181 A FI20160181 A FI 20160181A FI 20160181 A FI20160181 A FI 20160181A FI 20160181 A FI20160181 A FI 20160181A FI 20160181 A FI20160181 A FI 20160181A
- Authority
- FI
- Finland
- Prior art keywords
- nicotine
- linseed
- snuff
- composition
- crusade
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Abstract
The present invention relates to the field of non-smokable products, more specifically snuff type compositions. Specifically, the invention relates to a snuff-type composition, wherein said snuff-type composition comprises nicotine and linseed and not tobacco. Still, the present invention relates to a method of preparing a snuff-type composition comprising nicotine and linseed and not tobacco, to use of nicotine and linseed in a snuff-type composition as well as other uses related to a snuff-type composition or nicotine and linseed but not tobacco.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20160181A FI127620B (en) | 2016-07-12 | 2016-07-12 | Snuff-type composition of nicotine and crushed linseed |
EP17827056.7A EP3484312A4 (en) | 2016-07-12 | 2017-07-11 | A snuff-type composition and method and uses related thereto |
PCT/FI2017/050531 WO2018011470A1 (en) | 2016-07-12 | 2017-07-11 | A snuff-type composition and method and uses related thereto |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20160181A FI127620B (en) | 2016-07-12 | 2016-07-12 | Snuff-type composition of nicotine and crushed linseed |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20160181A true FI20160181A (en) | 2018-01-13 |
FI127620B FI127620B (en) | 2018-10-31 |
Family
ID=60952821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20160181A FI127620B (en) | 2016-07-12 | 2016-07-12 | Snuff-type composition of nicotine and crushed linseed |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3484312A4 (en) |
FI (1) | FI127620B (en) |
WO (1) | WO2018011470A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3773496T3 (en) | 2019-06-07 | 2022-02-28 | Ncp Nextgen As | ORAL BAG PRODUCT |
DK180339B1 (en) | 2019-06-07 | 2020-12-18 | Ncp Nextgen As | Nicotine pouch composition and pouch comprising such |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5503844A (en) * | 1993-05-18 | 1996-04-02 | Mli Acquisition Corp. Ii | Foam laminate transdermal patch |
GB9605116D0 (en) * | 1996-03-07 | 1996-05-08 | British American Tobacco Co | Smokable filler material for smoking articles |
US5948433A (en) * | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
US20030068376A1 (en) * | 2001-04-20 | 2003-04-10 | Lavipharm Laboratories Inc. | Intraoral delivery of nicotine for smoking cessation |
WO2007118653A2 (en) * | 2006-04-11 | 2007-10-25 | Koko Kosmetikvertrieb Gmbh & Co. Kg | Nanoparticle containing nicotine and/or cotinine, dispersions and use thereof |
US7726320B2 (en) * | 2006-10-18 | 2010-06-01 | R. J. Reynolds Tobacco Company | Tobacco-containing smoking article |
WO2010031552A1 (en) * | 2008-09-17 | 2010-03-25 | Niconovum Ab | Process for preparing snuff composition |
US10799548B2 (en) * | 2013-03-15 | 2020-10-13 | Altria Client Services Llc | Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
US11771127B2 (en) * | 2013-10-03 | 2023-10-03 | Altria Client Services Llc | Chewable dissolvable nicotine tablet |
US20150230516A1 (en) * | 2014-02-18 | 2015-08-20 | Jeffrey Daniel Stewart | Composition For Herbal Moist Snuff |
-
2016
- 2016-07-12 FI FI20160181A patent/FI127620B/en active IP Right Grant
-
2017
- 2017-07-11 WO PCT/FI2017/050531 patent/WO2018011470A1/en unknown
- 2017-07-11 EP EP17827056.7A patent/EP3484312A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2018011470A1 (en) | 2018-01-18 |
EP3484312A1 (en) | 2019-05-22 |
EP3484312A4 (en) | 2020-03-11 |
FI127620B (en) | 2018-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500599A1 (en) | Sweet flavor modifier | |
MX2019009861A (en) | Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof. | |
MY186135A (en) | Tobacco composition | |
MX2018002999A (en) | Stable inoculant compositions and methods for producing same. | |
JO3155B1 (en) | Sweet flavor modifier | |
MX2016016143A (en) | Substituted [1,2,4]triazole compounds. | |
MX2017003923A (en) | Use of isomerically pure or highly isomer-enriched cis- or trans-(2-isobutyl-4-methyl-tetrahydropyran-4-yl)acetate. | |
MX2020006596A (en) | Hydroxyisoxazolines and derivatives thereof. | |
WO2014121040A8 (en) | Flap modulators | |
WO2015092393A3 (en) | Ligands specifically binding to human targets of interest | |
WO2015055706A3 (en) | N-cycloalkyl-n-(biheterocyclymethylene)-(thio)carboxamide derivatives | |
EA033460B1 (en) | Substituted [1,2,4]triazole compounds as fungicides | |
WO2017171423A3 (en) | Nelumbo nucifera callus extract having increased content of gallic acid, method for preparing same, and whitening cosmetic composition containing same | |
WO2016102420A3 (en) | Novel isothiazolamides, processes for their preparation and their use as herbicides and/or plant growth regulators | |
WO2014121055A3 (en) | Flap modulators | |
PH12019500915A1 (en) | Composition useful to simulate tobacco aroma | |
WO2015171738A3 (en) | Fragrance compositions | |
WO2018126262A3 (en) | Smokeless products containing non-tobacco plant materials | |
CL2022003714A1 (en) | Methods and compositions for use in glued-wood products | |
AU2015313804A8 (en) | A flavor modifying composition, uses thereof and products comprising the same | |
FI20160181A (en) | Nicotine linseed seed crusade composition of snus | |
WO2014133811A3 (en) | Compounds from invasive salvinias and methods of using the same | |
WO2014121037A8 (en) | Hydroxylamine-terminated polysiloxane and methods of making and using the same | |
MX2017011222A (en) | Methods to increase corn growth. | |
MX2020008357A (en) | New pyridine carboxamides. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 127620 Country of ref document: FI Kind code of ref document: B |